⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 25, 2012Clinical Cancer Research

Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs

Ines Beyer Hua Cao Jonas Persson Hui Song Maximilian Richter Qinghua Feng Roma Yumul Ruan van Rensburg Zongyi Li Ronald Berenson Darrick Carter Steve R. Roffler Charles W. Drescher André Lieber

View at Publisher

Ask AI

Bookmark

Share

Abstract

Our preliminary data suggest that JO-1 cotherapy has the potential to improve the therapeutic outcome of cancer chemotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Beyer et al. (2012) studied this question.

synapsesocial.com/papers/69d969fcf20ef26330684e76 https://doi.org/10.1158/1078-0432.ccr-11-3213

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mechanistic bases for differences in passive absorptionOriginal Research · 2007 · 41 citations
2Stem cell property epithelial‐to‐mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild‐type tumor cellsOriginal Research · 2010 · 47 citations
3Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancerOriginal Research · 2005 · 88 citations
4Avidity Binding of Human Adenovirus Serotypes 3 and 7 to the Membrane Cofactor CD46 Triggers Infectionpreclinical · 2011 · 91 citations
5Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial JunctionsOriginal Research · 2011 · 90 citations

Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer2011
A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses2012
Sensitive Quantification of PEGylated Compounds by Second-Generation Anti-Poly(ethylene glycol) Monoclonal Antibodies2010
ENTRÉE Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung CancerClinical Cancer Research · 2026
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-arm non-comparative phase II trialClinical Cancer Research · 2026

More from Clinical Cancer Research

More from University of Washington

More from Fred Hutch Cancer Center

More from Institute of Biomedical Sciences, Academia Sinica